Pancreatic Neuroendocrine Tumors, WHO Grade I-II

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Pancreatic Neuroendocrine Tumors, WHO Grade I-II trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingNot Applicable

NCT05243082

Endoscopic Ultrasound Guided Radio Frequency Ablation of Pancreatic Neuroendocrine Neoplasms

A national multicenter prospective study to investigate the feasibility and efficacy of endoscopic ultrasound guided radiofrequency ablation of neuroendocrine p…

Norway20 participantsStarted 2022-01-14

Treatment: Radio frequency ablation

All recent trials (3 shown)

CompletedPhase 3

NCT00538850

Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain

This is a phase III, randomized, double-blind, placebo-controlled, multicenter study of the clinical response to fentanyl sublingual spray as a treatment for br…

United States130 participantsStarted 2007-10

Treatment: Fentanyl sublingual spray, Placebo

CompletedPhase 1

NCT00020579

MS-275 in Treating Patients With Advanced Solid Tumors or Lymphoma

RATIONALE: MS-275 may stop the growth of cancer cells by blocking the enzymes necessary for their growth. PURPOSE: This phase I trial is studying the side effe…

United States75 participantsStarted 2001-03

Treatment: entinostat